As of May 21
| +0.04 / +2.84%|
The 3 analysts offering 12-month price forecasts for Sierra Oncology Inc have a median target of 7.00, with a high estimate of 7.00 and a low estimate of 6.00. The median estimate represents a +382.76% increase from the last price of 1.45.
The current consensus among 3 polled investment analysts is to Buy stock in Sierra Oncology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.